UNSPSC 85502246: Destruction of left subclavian artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to destruction of left subclavian artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03543ZZ

UNSPSC 85502246 Destruction of left subclavian artery, percutaneous approach is a Commodity code with little relevant recent state and local procurement activity. The code's nominal scope describes a highly specific interventional surgical procedure, but recent state and local solicitations tagged under this code address occupational health surveillance, disability medical evaluations, surgical benefit management, pharmacy administration, and temporary health professional staffing—none of which align with percutaneous vascular intervention. The mismatch suggests that this code may have been applied by issuing bodies as a catch-all for medical services rather than to capture actual procurement of the specialized procedure the code describes.

State and local buyers recently posting under this code include the City of Phoenix Retirement Office (disability medical record summary and independent medical examination services, RFP RTMRFP26001, due October 16, 2026), the City of Long Beach (surgical benefit carve-out program management, RFP HR26753, due October 7, 2026), Washington State Department of Transportation on behalf of Washington State Ferries (occupational medical surveillance, RFP RFP20260825, due October 9, 2026), Harris County Juvenile Probation Department (emergency and specialty healthcare for detained youth, RFI 071626BNM, due September 25, 2026), Collier County Board of County Commissioners (pharmacy benefit management, RFP 25-8414, due April 9, 2026), and County of Santa Clara Health System (temporary ancillary health professional staffing, RFSQ RFSQHHSFY270052, due October 7, 2026). Geographic coverage spans Arizona, California, Florida, and Washington, with no dominant concentration in a single state. This code does not appear to reflect current state and local procurement intent for the specific vascular procedure it nominally describes.